F. E. Jansen, O. Van-nieuwenhuizen, A. Van-huffelen, R. De-hoogt, C. Hermans et al., Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34, 770. 2. van Slegtenhorst M, vol.75, pp.805-813, 1997.

A. R. Tee, D. C. Fingar, B. D. Manning, D. J. Kwiatkowski, L. C. Cantley et al., Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling, Proc Natl Acad Sci, vol.99, issue.21, pp.13571-13577, 2002.

K. Budde and J. Gaedeke, Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibition, Am J Kidney Dis Off J Natl Kidney Found, vol.59, issue.2, pp.276-83, 2012.

F. J. O'callaghan, A. W. Shiell, J. P. Osborne, and C. N. Martyn, Prevalence of tuberous sclerosis estimated by capture-recapture analysis, Lancet Lond Engl, vol.351, issue.9114, p.1490, 1998.

J. P. Osborne, A. Fryer, and D. Webb, Epidemiology of tuberous sclerosis, Ann N Y Acad Sci, vol.615, pp.125-132, 1991.

H. Northrup and D. A. Krueger, International Tuberous Sclerosis Complex Consensus Group

, Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference, vol.49, pp.243-54, 2013.

P. Curatolo, R. Bombardieri, and S. Jozwiak, Tuberous sclerosis, Lancet Lond Engl, vol.372, issue.9639, pp.657-68, 2008.

S. Samueli, K. Abraham, A. Dressler, G. Groeppel, C. Jonak et al., Tuberous Sclerosis Complex: new criteria for diagnostic work-up and management, Wien Klin Wochenschr, vol.127, pp.619-649, 2015.

C. W. Shepherd, M. R. Gomez, J. T. Lie, and C. S. Crowson, Causes of death in patients with tuberous sclerosis, Mayo Clin Proc, vol.66, issue.8, pp.792-798, 1991.

J. A. Cook, K. Oliver, R. F. Mueller, and J. Sampson, A cross sectional study of renal involvement in tuberous sclerosis, J Med Genet, vol.33, issue.6, pp.480-484, 1996.

F. J. O'callaghan, M. J. Noakes, C. N. Martyn, and J. P. Osborne, An epidemiological study of renal pathology in tuberous sclerosis complex, BJU Int, vol.94, issue.6, pp.853-860, 2004.

S. K. Rakowski, E. B. Winterkorn, E. Paul, D. Steele, E. F. Halpern et al., Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors, Kidney Int, vol.70, issue.10, pp.1777-82, 2006.

A. Volpi, G. Sala, E. Lesma, F. Labriola, M. Righetti et al., Tuberous sclerosis complex: new insights into clinical and therapeutic approach, J Nephrol, 2019.

, Eijkemans MJC, van der Wal W, Reijnders LJ, vol.32, pp.355-63

S. B. Khosrovani and C. Pelletier, Long-term Follow-up Assessing Renal Angiomyolipoma Treatment Patterns, Morbidity, and Mortality: An Observational Study in Tuberous Sclerosis Complex Patients in the Netherlands, Am J Kidney Dis Off J Natl Kidney Found, vol.66, issue.4, pp.638-683, 2015.

J. J. Bissler, J. C. Kingswood, E. Radzikowska, B. A. Zonnenberg, E. Belousova et al., Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study, PloS One, vol.12, issue.8, p.180939, 2017.

F. Schillinger and R. Montagnac, Chronic renal failure and its treatment in tuberous sclerosis

, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc, vol.11, issue.3, pp.481-486, 1996.

A. Clarke, E. Hancock, C. Kingswood, and J. P. Osborne, End-stage renal failure in adults with the tuberous sclerosis complex, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc, vol.14, issue.4, pp.988-91, 1999.

M. Lassalle, E. Monnet, C. Ayav, J. Hogan, O. Moranne et al., Annual Report Digest of the Renal Epidemiology Information Network (REIN) registry, Transpl Int, vol.32, issue.9, pp.892-902, 2017.

C. Couchoud, B. Stengel, P. Landais, J. Aldigier, F. De-cornelissen et al., The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France
URL : https://hal.archives-ouvertes.fr/hal-00452918

, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc, vol.21, issue.2, pp.411-419, 2006.

, Le rapport annuel REIN 2016-Agence de la biomédecine, 2018.

J. C. Kingswood, P. Bruzzi, P. Curatolo, P. J. De-vries, C. Fladrowski et al., TOSCAfirst international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex, Orphanet J Rare Dis, vol.9, p.182, 2014.

D. A. Krueger and H. Northrup, International Tuberous Sclerosis Complex Consensus Group

, Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference, vol.49, pp.255-65, 2013.

M. Davies, A. Saxena, and J. C. Kingswood, Management of everolimus-associated adverse events in patients with tuberous sclerosis complex: a practical guide, Orphanet J Rare Dis, vol.12, issue.1, p.35, 201715.

J. J. Bissler, K. Budde, M. Sauter, D. N. Franz, B. A. Zonnenberg et al., Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc, 2018.

J. C. Kingswood, E. Belousova, M. P. Benedik, T. Carter, V. Cottin et al., Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease Awareness, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc, vol.34, issue.3, pp.502-510, 2019.

R. D. Okada, M. A. Platt, and J. Fleishman, Chronic renal failure in patients with tuberous sclerosis. Association with renal cysts, Nephron, vol.30, issue.1, pp.85-93, 1982.

J. Bernstein, T. O. Robbins, and J. M. Kissane, The renal lesions of tuberous sclerosis, Semin Diagn Pathol, vol.3, issue.2, pp.97-105, 1986.